Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $73 million versus the consensus estimate of $72.28 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.